FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Brent Egan

Research Profile

Disorders

Concepts & Ideas

Risk Factors

Chemicals & Drugs

Procedures

Sodium-Restricted Diet

Geographic Areas

Physiology

Living Beings

European Continental Ancestry Group

Activities & Behaviors

Life Style

Co-author Network

Publications

TOP 3
Sandra M Coulon; Dawn K Wilson; Brent M Egan
Associations among environmental supports, physical activity, and blood pressure in African-American adults in the PATH trial.
Brent M Egan; Yumin Zhao
Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals.
Marilyn A Laken; Oscar Lovelace; Charles Way; Rosalind Dawson; Otis Engelman; Brent M Egan
Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Brent Egan (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Sandra M Coulon; Dawn K Wilson; Brent M Egan
Associations among environmental supports, physical activity, and blood pressure in African-American adults in the PATH trial.
Social science & medicine (1982) 2013;87():108-15.
2013: Brent M Egan; Yumin Zhao
Different definitions of prevalent hypertension impact: the clinical epidemiology of hypertension and attainment of Healthy People goals.
Journal of clinical hypertension (Greenwich, Conn.) 2013;15(3):154-61.
2013: Marilyn A Laken; Oscar Lovelace; Charles Way; Rosalind Dawson; Otis Engelman; Brent M Egan
Comparative effectiveness research in the "real" world: lessons learned in a study of treatment-resistant hypertension.
Journal of the American Society of Hypertension : JASH 2013;7(1):95-101.
2012: Joel Handler; Yumin Zhao; Brent M Egan
Impact of the number of blood pressure measurements on blood pressure classification in US adults: NHANES 1999-2008.
Journal of clinical hypertension (Greenwich, Conn.) 2012;14(11):751-9.
2012: Brent M Egan
Achievement of cardiometabolic goals in aware hypertensive patients in Spain: implications for population health.
Hypertension 2012;60(4):891-3.
2012: Tanya N Turan; Nicole Vilardo; Carole L White; Oscar Benavente; W Virgil Brown; Michelle F Caskey; Marc I Chimowitz; Colin P Derdeyn; Brent M Egan; David Fiorella; Kathie L Hermayer; Scott Janis; Bethany Lane; Ngoc-Anh Le; Maria F Lopes-Virella; Michael J Lynn; Azhar Nizam; Meghan R Steiner; Andrew Stufflebean
Rationale, design, and implementation of aggressive risk factor management in the Stenting and Aggressive Medical Management for Prevention of Recurrent Stroke in Intracranial Stenosis (SAMMPRIS) trial.
Circulation. Cardiovascular quality and outcomes 2012;5(5):e51-60.
2012: Brent M Egan; Stephanie R Shaftman; C Shaun Wagner; Dipankar Bandyopadhyay; Yumin Zhao; Kristina S Yu-Isenberg
Initial monotherapy and combination therapy and hypertension control the first year.
Hypertension 2012;59(6):1124-31.
2012: Brent M Egan; Stephanie R Shaftman; Dipankar Bandyopadhyay; C Shaun Wagner; Keith A Szymanski
Demographic differences in the treatment and control of glucose in type 2 diabetic patients: implications for health care practice.
Ethnicity & disease 2012;22(1):29-37.
2011: Anbesaw Selassie; C Shaun Wagner; Keith C Ferdinand; M LaFrance Ferguson; Marilyn L Laken; Brent M Egan
Progression is accelerated from prehypertension to hypertension in blacks.
Hypertension 2011;58(4):579-87.
2011: Brent M Egan
Renal sympathetic denervation: a novel intervention for resistant hypertension, insulin resistance, and sleep apnea.
Hypertension 2011;58(4):542-3.
2011: R Neal Axon; Laura Cousineau; Brent M Egan
Prevalence and management of hypertension in the inpatient setting: a systematic review.
Journal of hospital medicine : an official publication of the Society of Hospital Medicine 2011;6(7):417-22.
2011: Brent M Egan; R Neal Axon; Walter A Brzezinski; Yumin Zhao; Keith C Ferdinand
Uncontrolled and apparent treatment resistant hypertension in the United States, 1988 to 2008.
Circulation 2011;124(9):1046-58.
2011: Brent M Egan; Marilyn A Laken
Is blood pressure control to less than 140/less than 90 mmHg in 50% of all hypertensive patients as good as we can do in the USA: or is this as good as it gets?
Current opinion in cardiology 2011;26(4):300-7.
2011: Meghan Baruth; Marsha Dowda; Brent M Egan; Marilyn Laken; Sara Wilcox; Tatiana Y Warren
Cardiovascular disease risk factor clustering among African American adults.
Ethnicity & disease 2011;21(2):129-34.
2010: Brent M Egan
Overnight rostral fluid shift and obstructive sleep apnea in treatment resistant hypertension: connecting the dots clarifies the picture.
Hypertension 2010;56(6):1040-1.
2010: Brent M Egan; Daniel T Lackland; Daniel W Jones
Prehypertension: an opportunity for a new public health paradigm.
Cardiology clinics 2010;28(4):561-9.
2010: Brent M Egan; Marilyn A Laken; Jennifer L Donovan; Robert F Woolson
Does dark chocolate have a role in the prevention and management of hypertension?: commentary on the evidence.
Hypertension 2010;55(6):1289-95.
2010: Brent M Egan; Yumin Zhao; R Neal Axon
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.
JAMA : the journal of the American Medical Association 2010;303(20):2043-50.
2010: R Neal Axon; Paul Nietert; Brent M Egan
Antihypertensive medication prescribing patterns in a university teaching hospital.
Journal of clinical hypertension (Greenwich, Conn.) 2010;12(4):246-52.
2010: Y Al-Solaiman; Ammar Jesri; W K Mountford; Daniel T Lackland; Y Zhao; Brent M Egan
DASH lowers blood pressure in obese hypertensives beyond potassium, magnesium and fibre.
Journal of human hypertension 2010;24(4):237-46.
2009: Y Al-Solaiman; Ammar Jesri; Y Zhao; Jason D Morrow; Brent M Egan
Low-Sodium DASH reduces oxidative stress and improves vascular function in salt-sensitive humans.
Journal of human hypertension 2009;23(12):826-35.
2009: Brent M Egan; Jan Basile; Shakaib U Rehman; Phillip B Davis; Curt H Grob; Jessica Flynn Riehle; Christine A Walters; Daniel T Lackland; Carmen Merali; Jean E Sealey; John H Laragh
Plasma Renin test-guided drug treatment algorithm for correcting patients with treated but uncontrolled hypertension: a randomized controlled trial.
American journal of hypertension 2009;22(7):792-801.
2009: Brent M Egan
Fixed-dose combinations and hypertension control in community-based practices: application of the "keep-it-simple" principle.
Hypertension 2009;53(4):598-9.
2009: R Neal Axon; W David Bradford; Brent M Egan
The role of individual time preferences in health behaviors among hypertensive adults: a pilot study.
Journal of the American Society of Hypertension : JASH 2009;3(1):35-41.
2008: Daniel T Lackland; Brent M Egan; William K Mountford; Andrea D Boan; Denis A Evans; Gregory Gilbert; Daniel L McGee
Thirty-year Survival for Black and White Hypertensive Individuals in the Evans County Heart Study and the Hypertension Detection and Follow-up Program.
Journal of the American Society of Hypertension : JASH 2008;2(6):448-54.
2008: Brent M Egan
Sleep-disordered breathing and blood pressure in children.
Hypertension 2008;52(5):807.
2008: Brent M Egan; Stevo Julius
Prehypertension: risk stratification and management considerations.
Current hypertension reports 2008;10(5):359-66.
2008: Daniel T Lackland; Brent M Egan
Sodium intake and mortality: the debate continues.
Journal of general internal medicine 2008;23(9):1537-8.
2008: Brent M Egan; Shawna D Nesbitt; Stevo Julius
Prehypertension: should we be treating with pharmacologic therapy?
Therapeutic advances in cardiovascular disease 2008;2(4):305-14.
2008: Marvin Moser; Mark Houston; Laura Svetkey; Brent M Egan
Dietary management in the prevention and treatment of hypertension: does it work?
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(8):632-9.
2008: Setareh A Williams; Eric L Michelson; Valerie A Cain; Min Yang; Shawna D Nesbitt; Brent M Egan; Stevo Julius
An evaluation of the effects of an angiotensin receptor blocker on health-related quality of life in patients with high-normal blood pressure (prehypertension) in the Trial of Preventing Hypertension (TROPHY).
Journal of clinical hypertension (Greenwich, Conn.) 2008;10(6):436-42.
2008: Dana E King; Arch G Mainous; Brent M Egan; Robert F Woolson; Mark E Geesey
Effect of psyllium fiber supplementation on C-reactive protein: the trial to reduce inflammatory markers (TRIM).
Annals of family medicine 2008;6(2):100-6.
2008: Karl Andersen; Myron H Weinberger; Brent M Egan; Christian M Constance; Mohammed A Ali; James Jin; Deborah L Keefe
Comparative efficacy and safety of aliskiren, an oral direct renin inhibitor, and ramipril in hypertension: a 6-month, randomized, double-blind trial.
Journal of hypertension 2008;26(3):589-99.
2008: Stevo Julius; Niko A Kaciroti; Brent M Egan; Shawna Nesbitt; Eric L Michelson
TROPHY study: Outcomes based on the Seventh Report of the Joint National Committee on Hypertension definition of hypertension.
Journal of the American Society of Hypertension : JASH 2008;2(1):39-43.
2008: Jill E Abell; Brent M Egan; Peter W F Wilson; Stuart R Lipsitz; Robert F Woolson; Daniel T Lackland
Differences in cardiovascular disease mortality associated with body mass between Black and White persons.
American journal of public health 2008;98(1):63-6.
2007: Crystal A Gadegbeku; Arachelvi Dhandayuthapani; Timothy P Taylor; Zakarea Shrayyef; John Gerich; W Timothy Garvey; Brent M Egan
Insulin's actions on plasma free fatty acids are normal in patients with stage 2 to 3 chronic kidney disease.
Journal of the American Society of Hypertension : JASH 2007;1(6):414-22.
2007: Brent M Egan
Combination therapy with an angiotensin-converting enzyme inhibitor and a calcium channel blocker.
Journal of clinical hypertension (Greenwich, Conn.) 2007;9(10):783-9.
2007: Dana E King; Arch G Mainous; Brent M Egan; Marty S Player; Mark E Geesey
Use of statins and blood pressure.
American journal of hypertension 2007;20(9):937-41.
2007: Daniel T Lackland; Brent M Egan
Dietary salt restriction and blood pressure in clinical trials.
Current hypertension reports 2007;9(4):314-9.
2007: Jill E Abell; Brent M Egan; Peter W F Wilson; Stuart R Lipsitz; Robert F Woolson; Daniel T Lackland
Age and race impact the association between BMI and CVD mortality in women.
Public health reports (Washington, D.C. : 1974) 2007;122(4):507-12.
2007: Dana E King; Brent M Egan; Robert F Woolson; Arch G Mainous; Yaser Al-Solaiman; Ammar Jesri
Effect of a high-fiber diet vs a fiber-supplemented diet on C-reactive protein level.
Archives of internal medicine 2007;167(5):502-6.
2007: Stevo Julius; Anthony Schork; Brent M Egan
From TROPHY with pride.
American journal of hypertension 2007;20(3):342-3; author reply 343-5.
2007: Z Joyce Fan; Daniel T Lackland; Stuart R Lipsitz; Joyce S Nicholas; Brent M Egan; W Tim Garvey; Florence Hutchison
Geographical patterns of end-stage renal disease incidence and risk factors in rural and urban areas of South Carolina.
Health & place 2007;13(1):179-87.
2007: Theodosha S Gilliard; Daniel T Lackland; William K Mountford; Brent M Egan
Concordance between self-reported heights and weights and current and ideal body images in young adult African American men and women.
Ethnicity & disease 2007;17(4):617-23.
2006: Brent M Egan; Daniel T Lackland; Priscilla E Pemu; Katharine H Hendrix; Jan Basile; Shakaib U Rehman; Eni C Okonofua; Quarshie Alexander; Adesifayo Oduwole; Anekwe E Onwuanyi; James _ Reed; Chamberlain _ Obialo; Elizabeth Ofili
Cardiovascular risk factor control in communities--update from the ASH Carolinas-Georgia Chapter, the Hypertension Initiative, and the Community Physicians' Network.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(12):879-86.
2006: Franz H Messerli; Sripal Bangalore; Brent M Egan; Stevo Julius
Does life-long reduction in low-density lipoprotein cholesterol reduce the risk of new-onset hypertension?
The American journal of cardiology 2006;98(8):1122.
2006: Heno F Lopes; Brent M Egan
Autonomic dysregulation and the metabolic syndrome: pathologic partners in an emerging global pandemic.
Arquivos brasileiros de cardiologia 2006;87(4):538-47.
2006: Crystal A Gadegbeku; M Zakarea Shrayyef; Timothy P Taylor; Brent M Egan
Mechanism of lipid enhancement of alpha1-adrenoceptor pressor sensitivity in hypertension.
Journal of hypertension 2006;24(7):1383-9.
2006: Brent M Egan
Sleep and hypertension: burning the candle at both ends really is hazardous to your health.
Hypertension 2006;47(5):816-7.
2006: Stevo Julius; Shawna D Nesbitt; Brent M Egan; Michael A Weber; Eric L Michelson; Niko A Kaciroti; Henry R Black; Richard H Grimm; Franz H Messerli; Suzanne Oparil; M Anthony Schork
Feasibility of treating prehypertension with an angiotensin-receptor blocker.
The New England journal of medicine 2006;354(16):1685-97.
2006: Dana E King; Brent M Egan; Arch G Mainous; Mark E Geesey
The effect of extended-release metoprolol succinate on C-reactive protein levels in persons with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(4):257-60.
2006: Eni C Okonofua; Kit N Simpson; Ammar Jesri; Shakaib U Rehman; Valerie L Durkalski; Brent M Egan
Therapeutic inertia is an impediment to achieving the Healthy People 2010 blood pressure control goals.
Hypertension 2006;47(3):345-51.
2006: Peter M Miller; Claudia Spies; Tim Neumann; Martin A Javors; A M Hoyumpa; John D Roache; Amy Webb; Maryam Kashi; Francis E Sharkey; Raymond F Anton; Brent M Egan; Jan Basile; Shaun Nguyen; Michael F Fleming; Kathryn Sullivan Dillie
Alcohol biomarker screening in medical and surgical settings.
Alcoholism, clinical and experimental research 2006;30(2):185-93.
2006: Brent M Egan
Challenges and risks in attaining the systolic blood pressure goal of <130 mm Hg in all diabetic patients.
Journal of clinical hypertension (Greenwich, Conn.) 2006;8(1):50-2.
2005: Ammar Jesri; Eni C Okonofua; Brent M Egan
Platelet and white blood cell counts are elevated in patients with the metabolic syndrome.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(12):705-11; quiz 712-3.
2005: Robert E Coffee; Joyce S Nicholas; Brent M Egan; Zoran Rumboldt; Sabino D'Agostino; Sunil J Patel
Arterial compression of the retro-olivary sulcus of the medulla in essential hypertension: a multivariate analysis.
Journal of hypertension 2005;23(11):2027-31.
2005: Katharine H Hendrix; Susan Mayhan; Daniel T Lackland; Brent M Egan
Prevalence, treatment, and control of chest pain syndromes and associated risk factors in hypertensive patients.
American journal of hypertension 2005;18(8):1026-32.
2005: Jessica Flynn Riehle; Daniel T Lackland; Eni C Okonofua; Katharine H Hendrix; Brent M Egan
Ethnic differences in the treatment and control of hypertension in patients with diabetes.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(8):445-54.
2005: Shawna D Nesbitt; Stevo Julius; David Leonard; Brent M Egan; Melissa Grozinski
Is low-risk hypertension fact or fiction? cardiovascular risk profile in the TROPHY study.
American journal of hypertension 2005;18(7):980-5.
2005: Eni C Okonofua; Neal E Cutler; Daniel T Lackland; Brent M Egan
Ethnic differences in older americans: awareness, knowledge, and beliefs about hypertension.
American journal of hypertension 2005;18(7):972-9.
2005: Heather A Liszka; Arch G Mainous; Dana E King; Charles J Everett; Brent M Egan
Prehypertension and cardiovascular morbidity.
Annals of family medicine 2005;3(4):294-9.
2005: Brent M Egan; Jan Basile; Robert J Chilton; Jerome D Cohen
Cardioprotection: the role of beta-blocker therapy.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(7):409-16.
2005: Katharine H Hendrix; Susan Mayhan; Brent M Egan
Gender- and age-related differences in treatment and control of cardiovascular risk factors among high-risk patients with angina.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(7):386-94.
2005: Peter M Miller; Raymond F Anton; Brent M Egan; Jan Basile; Shaun Nguyen
Excessive alcohol consumption and hypertension: clinical implications of current research.
Journal of clinical hypertension (Greenwich, Conn.) 2005;7(6):346-51.
2005: William H Bestermann; Mark C Houston; Jan Basile; Brent M Egan; Carlos M Ferrario; Daniel T Lackland; Ralph G Hawkins; James _ Reed; Philip Rogers; Daniel Wise; Michael A Moore
Addressing the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome in the southeastern United States, part II: treatment recommendations for management of the global cardiovascular risk of hypertension, dyslipidemia, diabetes mellitus, and the metabolic syndrome.
The American journal of the medical sciences 2005;329(6):292-305.
2005: Mark C Houston; Jan Basile; William H Bestermann; Brent M Egan; Daniel T Lackland; Ralph G Hawkins; Michael A Moore; James _ Reed; Philip Rogers; Daniel Wise; Carlos M Ferrario
Addressing the global cardiovascular risk of hypertension, dyslipidemia, and insulin resistance in the southeastern United States.
The American journal of the medical sciences 2005;329(6):276-91.
2005: Dana E King; Arch G Mainous; Brent M Egan; Robert F Woolson; Mark E Geesey
Fiber and C-reactive protein in diabetes, hypertension, and obesity.
Diabetes care 2005;28(6):1487-9.
2005: Shakaib U Rehman; Florence Hutchison; Katharine H Hendrix; Eni C Okonofua; Brent M Egan
Ethnic differences in blood pressure control among men at Veterans Affairs clinics and other health care sites.
Archives of internal medicine 2005;165(9):1041-7.
2005: J B Standridge; Jean E Sealey; John H Laragh; M C Houston; H Gavras; R J Johnson; Jon D Blumenfeld; M Brown; Brent M Egan; J I Meltzer; T Shimosawa; T Fujita
A free-ranging roundtable discussion on hypertension.
Journal of human hypertension 2005;19(4):259-66.
2005: Nina Sheats; Yan Lin; Wenle Zhao; DeAnna E. Cheek; Daniel T Lackland; Brent M Egan
Prevalence, treatment, and control of hypertension among African Americans and Caucasians at primary care sites for medically under-served patients.
Ethnicity & disease 2005;15(1):25-32.
2005: Katharine H Hendrix; Jessica E Riehle; Brent M Egan
Ethnic, gender, and age-related differences in treatment and control of dyslipidemia in hypertensive patients.
Ethnicity & disease 2005;15(1):11-6.
2005: Brent M Egan; Vasilios Papademetriou; Marion Wofford; David Calhoun; Jyotika K. Fernandes; Jessica E Riehle; Shawna D Nesbitt; Eric L Michelson; Stevo Julius
Metabolic syndrome and insulin resistance in the TROPHY sub-study: contrasting views in patients with high-normal blood pressure.
American journal of hypertension 2005;18(1):3-12.
2004: Arch G Mainous; Charles J Everett; Heather A Liszka; Dana E King; Brent M Egan
Prehypertension and mortality in a nationally representative cohort.
The American journal of cardiology 2004;94(12):1496-500.
2004: Brent M Egan; Gilbert W Gleim; Jessica Panish
Use of losartan in diabetic patients in the primary care setting: review of the results in LIFE and RENAAL.
Current medical research and opinion 2004;20(12):1909-17.
2004: William H Bestermann; Daniel T Lackland; Jessica E Riehle; Brent M Egan
A systematic approach to managing hypertension and the metabolic syndrome in primary care.
Southern medical journal 2004;97(10):932-8.
2004: Dana E King; Brent M Egan; Arch G Mainous; Mark E Geesey
Elevation of C-reactive protein in people with prehypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(10):562-8.
2004: Brent M Egan
Hypertension in the 21st century: the tide is rising; our daze must end.
Hypertension 2004;44(4):389.
2004: Crystal A Gadegbeku; M Zakarea Shrayyef; Frankie B LaPorte; Brent M Egan
Lipids enhance alpha1-adrenoceptor pressor sensitivity in patients with chronic kidney disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(3):446-54.
2004: Stevo Julius; Shawna D Nesbitt; Brent M Egan; Niko A Kaciroti; M Anthony Schork; Melissa Grozinski; Eric L Michelson
Trial of preventing hypertension: design and 2-year progress report.
Hypertension 2004;44(2):146-51.
2004: Khaled Nashar; Jacqueline P Nguyen; Ammar Jesri; Jason D Morrow; Brent M Egan
Angiotensin receptor blockade improves arterial distensibility and reduces exercise-induced pressor responses in obese hypertensive patients with the metabolic syndrome.
American journal of hypertension 2004;17(6):477-82.
2004: Theodore L Goodfriend; Dennis L Ball; Brent M Egan; William B Campbell; Kasem Nithipatikom
Epoxy-keto derivative of linoleic acid stimulates aldosterone secretion.
Hypertension 2004;43(2):358-63.
2004: Daniel T Lackland; Yan Lin; Barbara C Tilley; Brent M Egan
An assessment of racial differences in clinical practices for hypertension at primary care sites for medically underserved patients.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(1):26-31; quiz 32-3.
2004: Jan Basile; Daniel T Lackland; Jeffrey M Basile; Jessica E Riehle; Brent M Egan
A statewide primary care approach to cardiovascular risk factor control in high-risk diabetic and nondiabetic patients with hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2004;6(1):18-25.
2003: Brent M Egan; Robert J Chilton
Other important applications for beta-blockers in high-risk patients.
Postgraduate medicine 2003;114(6 Suppl Role):35-48.
2003: Brent M Egan
Beta-blockers for cardioprotection. A forgotten message?
Postgraduate medicine 2003;114(6 Suppl Role):3.
2003: Dana E King; Brent M Egan; Mark E Geesey
Relation of dietary fat and fiber to elevation of C-reactive protein.
The American journal of cardiology 2003;92(11):1335-9.
2003: Brent M Egan; Jan Basile
Controlling blood pressure in 50% of all hypertensive patients: an achievable goal in the healthy people 2010 report?
Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2003;51(6):373-85.
2003: Katharine H Hendrix; Daniel T Lackland; Brent M Egan
Cardiovascular risk factor control and treatment patterns in primary care.
Managed care interface 2003;16(11):21-6.
2003: Brent M Egan
Reproducibility of BP responses to changes in dietary salt: compelling evidence for universal sodium restriction?
Hypertension 2003;42(4):457-8.
2003: Melanie Giese; Daniel T Lackland; Jan Basile; Brent M Egan
2003 update on the Hypertension Initiative of South Carolina. Bringing South Carolina from "worst to first" in cardiovascular health.
Journal of the South Carolina Medical Association (1975) 2003;99(6):157-61.
2003: Brent M Egan
Insulin resistance and the sympathetic nervous system.
Current hypertension reports 2003;5(3):247-54.
2003: Heno F Lopes; Jason D Morrow; Milos P Stojiljkovic; Theodore L Goodfriend; Brent M Egan; Milos P Stoijiljkovic
Acute hyperlipidemia increases oxidative stress more in African Americans than in white Americans.
American journal of hypertension 2003;16(5 Pt 1):331-6.
2003: Brent M Egan; Daniel T Lackland; Neal E Cutler
Awareness, knowledge, and attitudes of older americans about high blood pressure: implications for health care policy, education, and research.
Archives of internal medicine 2003;163(6):681-7.
2003: Daniel T Lackland; Brent M Egan; Pamela L Ferguson
Low birth weight as a risk factor for hypertension.
Journal of clinical hypertension (Greenwich, Conn.) 2003;5(2):133-6.
2003: Heno F Lopes; Kelley L Martin; Khaled Nashar; Jason D Morrow; Theodore L Goodfriend; Brent M Egan
DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity.
Hypertension 2003;41(3):422-30.
2003: Crystal A Gadegbeku; Arachelvi Dhandayuthapani; M Zakarea Shrayyef; Brent M Egan
Hemodynamic effects of nicotinic acid infusion in normotensive and hypertensive subjects.
American journal of hypertension 2003;16(1):67-71.
2002: George L Bakris; David Calhoun; Brent M Egan; Christopher Hellmann; Michael Dolker; Iris Kingma
Orlistat improves blood pressure control in obese subjects with treated but inadequately controlled hypertension.
Journal of hypertension 2002;20(11):2257-67.
2002: Brent M Egan
Ethnicity and unprovoked hypokalemia in the ARIC Study.
American journal of hypertension 2002;15(7 Pt 1):660-1.
2002: Crystal A Gadegbeku; Arachelvi Dhandayuthapani; Zara E Sadler; Brent M Egan
Raising lipids acutely reduces baroreflex sensitivity.
American journal of hypertension 2002;15(6):479-85.
2002: Milos P Stojiljkovic; Heno F Lopes; Da Zhang; Jason D Morrow; Theodore L Goodfriend; Brent M Egan
Increasing plasma fatty acids elevates F2-isoprostanes in humans: implications for the cardiovascular risk factor cluster.
Journal of hypertension 2002;20(6):1215-21.
2002: Heno F Lopes; Milos P Stojiljkovic; D Zhang; Theodore L Goodfriend; Brent M Egan
Moderate sodium restriction enhances the pressor response to hyperlipidemia in obese, hypertensive patients.
Journal of clinical hypertension (Greenwich, Conn.) 2002;4(3):173-80.
2002: Brent M Egan; Daniel T Lackland; Jan Basile
American Society of Hypertension regional chapters: leveraging the impact of the clinical hypertension specialist in the local community.
American journal of hypertension 2002;15(4 Pt 1):372-9.
2002: Kim Y Foster; Nancy S Diehl; Darlene Shaw; Rebecca L Rogers; Brent M Egan; Peter J Carek; Jim Tomsic
Medical students' readiness to provide lifestyle counseling for overweight patients.
Eating behaviors 2002;3(1):1-13.
2002: Daniel T Lackland; Brent M Egan; Holly E Syddall; David J P Barker
Associations between birth weight and antihypertensive medication in black and white medicaid recipients.
Hypertension 2002;39(1):179-83.
2001: Heno F Lopes; Milos P Stojiljkovic; Da Zhang; Theodore L Goodfriend; Brent M Egan
The pressor response to acute hyperlipidemia is enhanced in lean normotensive offspring of hypertensive parents.
American journal of hypertension 2001;14(10):1032-7.
2001: A Haastrup; Crystal A Gadegbeku; Da Zhang; Yurii V Mukhin; Eddie L Greene; Ayad A Jaffa; Brent M Egan
Lipids stimulate the production of 6-keto-prostaglandin f(1alpha) in human dorsal hand veins.
Hypertension 2001;38(4):858-63.
2001: Brent M Egan; Daniel T Lackland; B Williams; N Gunter; A Tocharoen; L Beardon
Health care improvement and cost reduction opportunities in hypertensive Medicaid beneficiaries.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(5):279-82, 318.
2001: Brent M Egan; Eddie L Greene; Theodore L Goodfriend
Insulin resistance and cardiovascular disease.
American journal of hypertension 2001;14(6 Pt 2):116S-125S.
2001: Milos P Stojiljkovic; Da Zhang; Heno F Lopes; C G Lee; Theodore L Goodfriend; Brent M Egan
Hemodynamic effects of lipids in humans.
American journal of physiology. Regulatory, integrative and comparative physiology 2001;280(6):R1674-9.
2001: Brent M Egan; Eddie L Greene; Theodore L Goodfriend
Nonesterified fatty acids in blood pressure control and cardiovascular complications.
Current hypertension reports 2001;3(2):107-16.
2001: M Giese; Daniel T Lackland; Brent M Egan
The hypertension initiative of South Carolina. Promoting cardiovascular health through better blood pressure control.
Journal of the South Carolina Medical Association (1975) 2001;97(2):57-62.
2001: Eddie L Greene; G Lu; Da Zhang; Brent M Egan
Signaling events mediating the additive effects of oleic acid and angiotensin II on vascular smooth muscle cell migration.
Hypertension 2001;37(2):308-12.
2001: MJ Oexmann; R Ascanio; Brent M Egan
Efficacy of a church-based intervention on cardiovascular risk reduction.
Ethnicity & disease 2001;11(4):817-22.
2001: Daniel T Lackland; Brent M Egan; Z Joyce Fan; H E Syddall
Low birth weight contributes to the excess prevalence of end-stage renal disease in African Americans.
Journal of clinical hypertension (Greenwich, Conn.) 2001;3(1):29-31.
2000: Brent M Egan; Daniel T Lackland
Biochemical and metabolic effects of very-low-salt diets.
The American journal of the medical sciences 2000;320(4):233-9.
2000: D Gajjar; Brent M Egan; J Curè; Philip F Rust; P VanTassel; Sunil J Patel
Vascular compression of the rostral ventrolateral medulla in sympathetic mediated essential hypertension.
Hypertension 2000;36(1):78-82.
2000: Daniel T Lackland; H E Bendall; C Osmond; Brent M Egan; D J Barker
Low birth weights contribute to high rates of early-onset chronic renal failure in the Southeastern United States.
Archives of internal medicine 2000;160(10):1472-6.
2000: MJ Oexmann; James C. Thomas; K B Taylor; Patrick M O'Neil; W Timothy Garvey; Daniel T Lackland; Brent M Egan
Short-term impact of a church-based approach to lifestyle change on cardiovascular risk in African Americans.
Ethnicity & disease 2000;10(1):17-23.
1999: Daniel T Lackland; Brent M Egan
The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States.
The American journal of the medical sciences 1999;318(6):365-8.
1999: D Jones; Jan Basile; William Cushman; Brent M Egan; Carlos M Ferrario; Martha N Hill; Daniel T Lackland; George Mensah; M Moore; Elizabeth Ofili; Edward J Roccella; R Smith; H Taylor
Managing hypertension in the southeastern United States: applying the guidelines from the Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI).
The American journal of the medical sciences 1999;318(6):357-64.
1999: Daniel T Lackland; Brent M Egan; P J Jones
Impact of nativity and race on "Stroke Belt" mortality.
Hypertension 1999;34(1):57-62.
1999: Brent M Egan; G Lu; Eddie L Greene
Vascular effects of non-esterified fatty acids: implications for the cardiovascular risk factor cluster.
Prostaglandins, leukotrienes, and essential fatty acids 1999;60(5-6):411-20.
1999: Theodore L Goodfriend; Brent M Egan; D E Kelley
Plasma aldosterone, plasma lipoproteins, obesity and insulin resistance in humans.
Prostaglandins, leukotrienes, and essential fatty acids 1999;60(5-6):401-5.
1998: G Lu; Eddie L Greene; T Nagai; Brent M Egan
Reactive oxygen species are critical in the oleic acid-mediated mitogenic signaling pathway in vascular smooth muscle cells.
Hypertension 1998;32(6):1003-10.
1998: A T Haastrup; KT Stepniakowski; Theodore L Goodfriend; Brent M Egan
Intralipid enhances alpha1-adrenergic receptor mediated pressor sensitivity.
Hypertension 1998;32(4):693-8.
1998: Theodore L Goodfriend; Brent M Egan; D E Kelley
Aldosterone in obesity.
Endocrine research 1998;24(3-4):789-96.
1998: B M Barone; Brent M Egan; T E Brown; M L Resch; L J Woodard; K P Trogdon; Daniel T Lackland
Commun-I-Care: experience in the first four years.
Journal of the South Carolina Medical Association (1975) 1998;94(7):318-22.
1998: G Lu; K E Meier; Ayad A Jaffa; Steven A Rosenzweig; Brent M Egan
Oleic acid and angiotensin II induce a synergistic mitogenic response in vascular smooth muscle cells.
Hypertension 1998;31(4):978-85.
1998: Brent M Egan; Daniel T Lackland
Strategies for cardiovascular disease prevention: importance of public and community health programs.
Ethnicity & disease 1998;8(2):228-39.
1997: KT Stepniakowski; G Lu; R K Davda; Brent M Egan
Fatty acids augment endothelium-dependent dilation in hand veins by a cyclooxygenase-dependent mechanism.
Hypertension 1997;30(6):1634-9.
1997: KT Stepniakowski; G Lu; G D Miller; Brent M Egan
Fatty acids, not insulin, modulate alpha1-adrenergic reactivity in dorsal hand veins.
Hypertension 1997;30(5):1150-5.
1997: Theodore L Goodfriend; Brent M Egan
Nonesterified fatty acids in the pathogenesis of hypertension: theory and evidence.
Prostaglandins, leukotrienes, and essential fatty acids 1997;57(1):57-63.
1997: W Dallas Hall; C M Ferrario; M A Moore; J E Hall; John M Flack; W Cooper; J D Simmons; Brent M Egan; Daniel T Lackland; M Perry; E J Roccella
Hypertension-related morbidity and mortality in the southeastern United States.
The American journal of the medical sciences 1997;313(4):195-209.
1997: Brent M Egan; KT Stepniakowski
Adverse effects of short-term, very-low-salt diets in subjects with risk-factor clustering.
The American journal of clinical nutrition 1997;65(2 Suppl):671S-677S.
1997: DA McCarron; Alan B Weder; Brent M Egan; G G Krishna; Cynthia Morris; M Cohen; S Oparil
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients.
American journal of hypertension 1997;10(1):68-76.
1996: G Lu; Thomas A Morinelli; Kathryn E Meier; Steven A Rosenzweig; Brent M Egan
Oleic acid-induced mitogenic signaling in vascular smooth muscle cells. A role for protein kinase C.
Circulation research 1996;79(3):611-8.
1996: Charles N Alexander; Robert H Schneider; F Staggers; W Sheppard; B M Clayborne; M Rainforth; J Salerno; Kofi Kondwani; S Smith; Kenneth G Walton; Brent M Egan
Trial of stress reduction for hypertension in older African Americans. II. Sex and risk subgroup analysis.
Hypertension 1996;28(2):228-37.
1996: M M Hennes; I M O'Shaughnessy; T M Kelly; P LaBelle; Brent M Egan; Ahmed H Kissebah
Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system.
Hypertension 1996;28(1):120-6.
1996: KT Stepniakowski; Floyd R Sallee; Theodore L Goodfriend; Z Zhang; Brent M Egan
Fatty acids enhance neurovascular reflex responses by effects on alpha 1-adrenoceptors.
The American journal of physiology 1996;270(6 Pt 2):R1340-6.
1996: Michael E Ullian; Debra J Hazen-Martin; L G Walsh; R K Davda; Brent M Egan
Carbenoxolone damages endothelium and enhances vasoconstrictor action in aortic rings.
Hypertension 1996;27(6):1346-52.
1996: Brent M Egan; M M Hennes; KT Stepniakowski; I M O'Shaughnessy; Ahmed H Kissebah; Theodore L Goodfriend
Obesity hypertension is related more to insulin's fatty acid than glucose action.
Hypertension 1996;27(3 Pt 2):723-8.
1995: R K Davda; KT Stepniakowski; G Lu; Michael E Ullian; Theodore L Goodfriend; Brent M Egan
Oleic acid inhibits endothelial nitric oxide synthase by a protein kinase C-independent mechanism.
Hypertension 1995;26(5):764-70.
1995: I M O'Shaughnessy; T J Myers; KT Stepniakowski; P Nazzaro; T M Kelly; RG Hoffmann; Brent M Egan; Ahmed H Kissebah
Glucose metabolism in abdominally obese hypertensive and normotensive subjects.
Hypertension 1995;26(1):186-92.
1995: Sverre E Kjeldsen; Alan B Weder; Brent M Egan; Richard Neubig; AJ Zweifler; Stevo Julius
Effect of circulating epinephrine on platelet function and hematocrit.
Hypertension 1995;25(5):1096-105.
1995: KT Stepniakowski; Theodore L Goodfriend; Brent M Egan
Fatty acids enhance vascular alpha-adrenergic sensitivity.
Hypertension 1995;25(4 Pt 2):774-8.
1995: KT Stepniakowski; Brent M Egan
Additive effects of obesity and hypertension to limit venous volume.
The American journal of physiology 1995;268(2 Pt 2):R562-8.
1995: Theodore L Goodfriend; Brent M Egan; KT Stepniakowski; Dennis L Ball
Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans.
Hypertension 1995;25(1):30-6.
1994: D Kenny; Brent M Egan
Is there a role for dietary fish oil in the treatment of hypertension?
Journal of human hypertension 1994;8(12):895-905.
1994: Brent M Egan; KT Stepniakowski; Theodore L Goodfriend
Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering.
American journal of hypertension 1994;7(10 Pt 1):886-93.
1994: Brent M Egan; KT Stepniakowski
Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives.
Journal of hypertension 1994;12(9):1061-7.
1994: P Nazzaro; KT Stepniakowski; I M O'Shaughnessy; Ahmed H Kissebah; Brent M Egan
Elevated blood pressures in obese young men with mild hypertension are sustained during the day and night.
American journal of hypertension 1994;7(7 Pt 1):609-14.
1994: Brent M Egan; KT Stepniakowski; P Nazzaro
Insulin levels are similar in obese salt-sensitive and salt-resistant hypertensive subjects.
Hypertension 1994;23(1 Suppl):I1-7.
1994: Brent M Egan; KT Stepniakowski; AJ Zweifler
Ketanserin's sympatholytic and serotonin2-receptor blocking actions precede the hypotensive effects.
Journal of human hypertension 1994;8(1):59-64.
1993: J M Neahring; KT Stepniakowski; Andrew S Greene; Brent M Egan
Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men.
Hypertension 1993;22(4):584-90.
1993: Brent M Egan; M J Fleissner; KT Stepniakowski; J M Neahring; Kiran Sagar; Thomas J Ebert
Improved baroreflex sensitivity in elderly hypertensives on lisinopril is not explained by blood pressure reduction alone.
Journal of hypertension 1993;11(10):1113-20.
1993: Brent M Egan; KT Stepniakowski
Effects of enalapril on the hyperinsulinemic response to severe salt restriction in obese young men with mild systemic hypertension.
The American journal of cardiology 1993;72(1):53-7.
1993: H H Shin; Kiran Sagar; KT Stepniakowski; J N Wetherbee; Brent M Egan
Increased prevalence of abnormal signal-averaged electrocardiograms in older patients who have hypertension with low diastolic blood pressure.
American heart journal 1993;125(6):1698-703.
1992: D Kenny; David C Warltier; Joan Pleuss; RG Hoffmann; T L Goodfriend; Brent M Egan
Effect of omega-3 fatty acids on the vascular response to angiotensin in normotensive men.
The American journal of cardiology 1992;70(15):1347-52.
1992: Brent M Egan
Hypertension, diuretics, and coronary heart disease: a case of apples and oranges, reciprocal prejudice, and a partially-clad emperor?
American journal of hypertension 1992;5(9):665-6.
1992: G Sorokin; N M Grant; Brent M Egan; Julian H Lombard
Cyclooxygenase products do not modulate angiotensin II-induced contractions of human chorionic plate arteries.
American journal of obstetrics and gynecology 1992;167(1):110-4.
1992: Brent M Egan
Adaptive changes in cerebral blood vessels during chronic hypertension.
Journal of hypertension 1992;10(4):399-400.
1992: Brent M Egan
Cardiovascular risk factors, clustering and complications in overweight young men.
Medical Section proceedings : the ... annual Meeting of the Medical Section of the American Council of Life Insurance. American Council of Life Insurance. Medical Section. Meeting 1992;():107-15.
1991: Brent M Egan; J Petrin; R G Hoffmann
NaCl induces differential changes of regional vascular reactivity in salt-sensitive versus salt-resistant men.
American journal of hypertension 1991;4(12 Pt 1):924-31.
1991: Brent M Egan
Neurohumoral, hemodynamic and microvascular changes as mechanisms of insulin resistance in hypertension: a provocative but partial picture.
International journal of obesity 1991;15 Suppl 2():133-9.
1991: Theodore L Goodfriend; Dennis L Ball; M H Weinberger; T J Moore; Alan B Weder; Brent M Egan
Salt loads raise plasma fatty acids and lower insulin.
Hypertension 1991;17(6 Pt 2):958-64.
1991: Brent M Egan; Alan B Weder; J Petrin; Raymond G Hoffman
Neurohumoral and metabolic effects of short-term dietary NaCl restriction in men. Relationship to salt-sensitivity status.
American journal of hypertension 1991;4(5 Pt 1):416-21.
1991: Brent M Egan; D R Bassett; W D Block
Comparative effects of overweight on cardiovascular risk in younger versus older men.
The American journal of cardiology 1991;67(4):248-52.
1991: Alan B Weder; Brent M Egan
Potential deleterious impact of dietary salt restriction on cardiovascular risk factors.
Klinische Wochenschrift 1991;69 Suppl 25():45-50.
1990: M A Sekkarie; Brent M Egan; Richard Neubig; Mark A Supiano
Sensitization of human alpha 1- and alpha 2-adrenergic venous responses by guanadrel sulfate.
Clinical pharmacology and therapeutics 1990;48(5):537-43.
1990: A D Mejia; Brent M Egan; N J Schork; AJ Zweifler
Artefacts in measurement of blood pressure and lack of target organ involvement in the assessment of patients with treatment-resistant hypertension.
Annals of internal medicine 1990;112(4):270-7.
1989: Brent M Egan
Neurogenic mechanisms initiating essential hypertension.
American journal of hypertension 1989;2(12 Pt 2):357S-362S.
1989: J Petrin; Brent M Egan; Stevo Julius
Increased beta-adrenergic tone enhances arterial compliance in hyperkinetic borderline hypertension.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1989;7(6):S78-9.
1989: Brent M Egan; M A Fitzpatrick; J Juni; AJ Buda; AJ Zweifler
Importance of overweight in studies of left ventricular hypertrophy and diastolic function in mild systemic hypertension.
The American journal of cardiology 1989;64(12):752-5.
1989: Brent M Egan; N J Schork; Alan B Weder
Regional hemodynamic abnormalities in overweight men. Focus on alpha-adrenergic vascular responses.
American journal of hypertension 1989;2(6 Pt 1):428-34.
1989: J Dananberg; Brent M Egan; Eric R Bates; Roger J Grekin
Sustained saline-induced secretion of atrial natriuretic hormone is not maintained by atrial stretch.
The Journal of clinical endocrinology and metabolism 1989;68(4):735-9.
1988: Alan B Weder; Brent M Egan
Erythrocyte water, Na+-K+ cotransport, and forearm vascular function in humans.
Hypertension 1988;12(2):199-203.
1988: Brent M Egan; Robert Schmouder
The importance of hemodynamic considerations in essential hypertension.
American heart journal 1988;116(2 Pt 2):594-9.
1988: Brent M Egan; M E Conlon; R Campbell; N Schork; A Zwiefler; Stevo Julius
Effects of ketanserin on blood pressure and platelet aggregation in elderly men with mild hypertension.
American journal of hypertension 1988;1(3 Pt 3):324S-330S.
1988: Brent M Egan; N Schork; R Panis; Alan L Hinderliter
Vascular structure enhances regional resistance responses in mild essential hypertension.
Journal of hypertension 1988;6(1):41-8.
1987: Brent M Egan; R Panis; Alan L Hinderliter; N Schork; Stevo Julius
Mechanism of increased alpha adrenergic vasoconstriction in human essential hypertension.
The Journal of clinical investigation 1987;80(3):812-7.
1987: Alan B Weder; M A Fitzpatrick; B A Torretti; Alan L Hinderliter; Brent M Egan; Stevo Julius
Red blood cell Li+-Na+ countertransport, Na+-K+ cotransport, and the hemodynamics of hypertension.
Hypertension 1987;9(5):459-66.
1987: Brent M Egan; M A Fitzpatrick; Stevo Julius
The heart and the regulation of renin.
Circulation 1987;75(1 Pt 2):I130-3.
1986: M A Fitzpatrick; Alan L Hinderliter; Brent M Egan; Stevo Julius
Decreased venous distensibility and reduced renin responsiveness in hypertension.
Hypertension 1986;8(6 Pt 2):II36-43.
1986: R H Schneider; Brent M Egan; E H Johnson; H Drobny; Stevo Julius
Anger and anxiety in borderline hypertension.
Psychosomatic medicine 1986;48(3-4):242-8.
1986: Brent M Egan
Management of the patient with borderline hypertension.
Journal of cardiovascular pharmacology 1986;8 Suppl 5():S103-7.
1985: Brent M Egan; Richard Neubig; Stevo Julius
Pharmacologic reduction of sympathetic drive increases platelet alpha-2-receptor number.
Clinical pharmacology and therapeutics 1985;38(5):519-24.
1985: Brent M Egan
Nutritional and lifestyle approaches to the prevention and management of hypertension.
Comprehensive therapy 1985;11(8):15-20.
1985: Brent M Egan; Stevo Julius
Vascular hypertrophy in borderline hypertension: relationship to blood pressure and sympathetic drive.
Clinical and experimental hypertension. Part A, Theory and practice 1985;7(2-3):243-55.
1985: Brent M Egan; Richard Neubig; Robert H Schneider; Stevo Julius
Methods for measuring vascular and nonvascular alpha-receptor sensitivity in humans.
Journal of cardiovascular pharmacology 1985;7 Suppl 6():S153-8.
1984: Brent M Egan; Roger J Grekin; H Ibsen; K Osterziel; Stevo Julius
Role of cardiopulmonary mechanoreceptors in ADH release in normal humans.
Hypertension 1984;6(6 Pt 1):832-6.
1983: Brent M Egan; Stevo Julius; C Cottier; K J Osterziel; H Ibsen
Role of cardiovascular receptors on the neural regulation of renin release in normal men.
Hypertension 1983;5(5):779-86.
1983: Stevo Julius; C Cottier; Brent M Egan; H Ibsen; W Kiowski
Cardiopulmonary mechanoreceptors and renin release in humans.
Federation proceedings 1983;42(10):2703-8.
1983: Brent M Egan; Stevo Julius
Borderline hypertension.
Primary care 1983;10(1):99-113.
1983: H Ibsen; Brent M Egan; K Osterziel; A Vander; Stevo Julius
Reflex-hemodynamic adjustments and baroreflex sensitivity during converting enzyme inhibition with MK-421 in normal humans.
Hypertension 1983;5(2 Pt 2):I184-91.